aTYR PHARMA ATYR
NASDAQ ATYR
$0.17 0.00 (-2.88%)
At close: Oct 23, 2026 · 4:00 PM EDT

aTYR PHARMA (ATYR) Depreciation & Amortization (CF) (2014 - 2026)

Updated

aTYR PHARMA's Depreciation & Amortization (CF) came in at $168,000 for Q2 2026, up 1.2% from $166,000 a year earlier and up 3.7% from the prior quarter.

Analysis

aTYR PHARMA (ATYR) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, aTYR PHARMA reported Depreciation & Amortization (CF) of $697,000, up 1.6% year-over-year; for FY2025, it was $700,000, down 1.1% from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 3.1% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $708,000 in FY2024 (+18.0%), $600,000 in FY2023 (+158.6%), $232,000 in FY2022 (-53.6%) and $500,000 in FY2021 (-16.7%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is $39,000 (Q4 2022) to $202,000 (Q4 2025).
  • Year-over-year, Depreciation & Amortization (CF) increased in three of the last eight quarters, with an average decline of 1.2%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q4 2023 (growth of 369.2%), and the weakest in Q4 2022 (a decline of 70.7%).
  • Business Quant data shows ATYR's Depreciation & Amortization (CF) at $162,000 (Q1 2026), $202,000 (Q4 2025) and $165,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 2.12 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 194.00 Mn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 1.93 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 98.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 1.62 Bn
10 aTYR PHARMA 16.22 Mn -276.60 Mn - 168,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 168,000.00
Mar 31, 2026 162,000.00
Dec 31, 2025 202,000.00
Sep 30, 2025 165,000.00
Jun 30, 2025 166,000.00
Mar 31, 2025 167,000.00
Dec 31, 2024 175,000.00
Sep 30, 2024 178,000.00
Jun 30, 2024 177,000.00
Mar 31, 2024 178,000.00
Dec 31, 2023 183,000.00
Sep 30, 2023 176,000.00
Jun 30, 2023 161,000.00
Mar 31, 2023 80,000.00
Dec 31, 2022 39,000.00
Sep 30, 2022 49,000.00
Jun 30, 2022 63,000.00
Mar 31, 2022 81,000.00
Dec 31, 2021 133,000.00
Sep 30, 2021 123,000.00
API Access

aTYR PHARMA Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ATYR&period=max&api_key=YOUR_API_KEY